The novel treatment of the medication represents a significant development in the care of type 2 diabetes. Different to existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide508183.actoblog.com/42967524/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment